Trials / Completed
CompletedNCT04706273
GORE® VIABAHN® Endoprosthesis Post-Marketing Surveillance Study (JPS 16-03)
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 321 (actual)
- Sponsor
- W.L.Gore & Associates · Industry
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This study will confirm device efficacy and safety in the clinical setting after the launch of the GORE® VIABAHN® Endoprosthesis for the treatment of symptomatic peripheral arterial disease in the superficial femoral arteries.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | GORE® VIABAHN® Endoprosthesis | Participants receiving the GORE® VIABAHN® Endoprosthesis |
Timeline
- Start date
- 2016-08-25
- Primary completion
- 2019-07-11
- Completion
- 2022-12-14
- First posted
- 2021-01-12
- Last updated
- 2024-09-20
- Results posted
- 2024-09-20
Locations
1 site across 1 country: Japan
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT04706273. Inclusion in this directory is not an endorsement.